I was lucky to get in just moments before this announcement and pick up another 77000 shares at NZ .066 cents (Au .062 cents). couldn't resist, (I'd back the truck right up if I had more funds!).
The Truscreen devise is clearly a disruptive technology ( on a per test basis, its overall performance is more accurate, faster, and cheaper than other testing alternatives). IMHO one should have no doubt that it will gradually become adopted by more and more health authorities world over.
The company also mentioned in the annual report "The Company is also actively looking at opportunities to expand its medical products range to capitalise on the technical ability of our team and to provide our distributors with a broader access to market."
so I wouldn't be too surprised if some day we acquire some other new technology to add to the quiver
